At ICDRA 2024, Smt. Anupriya Patel emphasised India’s regulatory reforms, highlighting new drug and medical device rules and collaboration with global regulatory bodies
MHRA concludes there is no evidence to support a connection between GLP-1 receptor agonists, including Novo Nordisk's Wegovy, and suicide-related risks
Ensuring patient safety and compliance, pharmacists must strictly adhere to prescription guidelines to prevent errors and promote responsible medication use.
